[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

CA2056364A1 - Compositions and methods of effecting contraception - Google Patents

Compositions and methods of effecting contraception

Info

Publication number
CA2056364A1
CA2056364A1 CA002056364A CA2056364A CA2056364A1 CA 2056364 A1 CA2056364 A1 CA 2056364A1 CA 002056364 A CA002056364 A CA 002056364A CA 2056364 A CA2056364 A CA 2056364A CA 2056364 A1 CA2056364 A1 CA 2056364A1
Authority
CA
Canada
Prior art keywords
compositions
methods
melatonin
effecting contraception
analog
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002056364A
Other languages
French (fr)
Other versions
CA2056364C (en
Inventor
Michael Cohen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Applied Medical Research Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2056364A1 publication Critical patent/CA2056364A1/en
Application granted granted Critical
Publication of CA2056364C publication Critical patent/CA2056364C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A method of effecting contraception in human females comprises administering an ovulation-inhibiting amount of melatonin or an analog of melatonin. Optionally, the melatonin or melatonin analog is administered in combination with a progestogen and/or an estrogen.
CA002056364A 1989-05-17 1990-05-17 Compositions and methods of effecting contraception Expired - Fee Related CA2056364C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35301989A 1989-05-17 1989-05-17
US353,019 1989-05-17
PCT/NL1990/000073 WO1990014084A1 (en) 1989-05-17 1990-05-17 Use of melatonin derivatives for effecting contraception

Publications (2)

Publication Number Publication Date
CA2056364A1 true CA2056364A1 (en) 1990-11-18
CA2056364C CA2056364C (en) 2002-08-20

Family

ID=23387406

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002056364A Expired - Fee Related CA2056364C (en) 1989-05-17 1990-05-17 Compositions and methods of effecting contraception

Country Status (15)

Country Link
EP (1) EP0472628A1 (en)
JP (1) JPH05500207A (en)
KR (1) KR920700637A (en)
CN (1) CN1047974A (en)
CA (1) CA2056364C (en)
DD (1) DD300071A5 (en)
EG (1) EG19554A (en)
FI (1) FI915395A0 (en)
HU (2) HUT60134A (en)
MW (1) MW6691A1 (en)
NZ (1) NZ233697A (en)
OA (1) OA09562A (en)
PT (1) PT94074A (en)
WO (1) WO1990014084A1 (en)
ZA (1) ZA903811B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA928011B (en) * 1991-10-18 1993-06-23 Alza Corp Transdermal administration of melatonin.
JP4745491B2 (en) * 2000-10-11 2011-08-10 株式会社明治 Indole long-chain alcohol and medicine containing the same
US7407983B2 (en) 2002-02-13 2008-08-05 Meiji Dairies Corporation Indole derivatives substituted with long-chain alcohols and medicaments containing them
CN111849934B (en) * 2019-04-26 2022-06-03 西南大学 Yuesang Da Shi N-acetyl-5-hydroxytryptamine oxygen methyltransferase and its application

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4614807A (en) * 1984-10-04 1986-09-30 Eli Lilly And Company 6,7-dihalomelatonins
CA1299174C (en) * 1987-02-02 1992-04-21 Michael Edward Flaugh Alkylmelatonins
US4855305A (en) * 1987-03-23 1989-08-08 Applied Medical Research Compositions and methods of effecting contraception utilizing melatonin

Also Published As

Publication number Publication date
EG19554A (en) 1995-06-29
CN1047974A (en) 1990-12-26
PT94074A (en) 1991-01-08
MW6691A1 (en) 1993-07-14
WO1990014084A1 (en) 1990-11-29
NZ233697A (en) 1996-12-20
ZA903811B (en) 1991-03-27
HU210342A9 (en) 1995-03-28
CA2056364C (en) 2002-08-20
OA09562A (en) 1993-01-31
HU905255D0 (en) 1992-01-28
HUT60134A (en) 1992-08-28
KR920700637A (en) 1992-08-10
DD300071A5 (en) 1992-05-21
FI915395A0 (en) 1991-11-15
EP0472628A1 (en) 1992-03-04
JPH05500207A (en) 1993-01-21

Similar Documents

Publication Publication Date Title
AU1683088A (en) Compositions and methods of effecting contraception and control of breast cancer
AU560487B2 (en) Contraceptive comprising gestodene and ethinylestradiol
CA2181742A1 (en) Reduction of skin irritation during electrotransport delivery
AU6747790A (en) Extraluminal regulation of the growth and repair of tubular structures in vivo
CA2088778A1 (en) Transdermal contraceptive formulations, methods and devices
AU645382B2 (en) Low estrogen oral contraceptives
CA2222133A1 (en) Transdermal patch and method for administering 17-deacetyl norgestimate alone or in combination with an estrogen
IL107490A0 (en) Therapeutic and diagnostic compositions with a modified cloud point and their preparation
CA2206233A1 (en) Combination dosage form comprising cetirizine and pseudoephedrine
NZ219776A (en) 11-substituted steroid 17, 2'-furan derivatives and pharmaceutical compositions
AU2252388A (en) Compositions and in situ methods for forming films on body tissue
CA2131911A1 (en) Minimizing progestin associated breakthrough bleeding
AU3431389A (en) 9-alpha-hydroxy-17-methylene steroids, process for their preparation and their use in the preparation of corticosteroids
EP0343730A3 (en) Wideband class ab crt cathode driver
CA2056364A1 (en) Compositions and methods of effecting contraception
AU2887889A (en) Use of cyclophilin as an anti-inflammatory and immunomodulatory agent
GR900100369A (en) Contraception compositions and methods
AU4204689A (en) Hollow viscus and solid organ tonometry
IE890229L (en) Use of cyclophilin as an anti-inflammatory and¹immunomodulatory agent

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed
MKLA Lapsed

Effective date: 20060517